12-Oct-2026      13:23

Jubilant Pharmova seeks to raise Rs 800 crore via private placement of NCDs

Jubilant Pharmova Limited announced the board’s approval to raise up to Rs 800 crore through the issuance of up to 80,000 fully paid-up, rupee-denominated, secured/unsecured, listed, rated, redeemable non-convertible debentures (NCDs) with a face value of Rs 1,00,000 each, on a private placement basis, potentially in multiple tranches, subject to regulatory approvals. Additionally, the company seeks shareholder authorization via a special resolution through postal ballot to issue non-convertible debt securities on a private placement basis for an aggregate amount not exceeding Rs 2,500 crore over a one-year period. The NCDs are planned to be listed on the Bombay Stock Exchange (BSE), with a tenure of up to five years and coupon/interest rates to be determined through a bidding process.

News source: Capital Market - Live News